Alerts will be sent to your verified email
Verify Email
VILINBIO
|
Vilin Bio Med
|
Bandaram Pharma Pack
|
Lasa Supergenerics
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
3.09 % | 5.64 % | -8.32 % |
|
5yr average Equity Multiplier
|
1.6 | 4.09 | 1.44 |
|
5yr Average Asset Turnover Ratio
|
0.68 | 0.98 | 0.77 |
|
5yr Avg Net Profit Margin
|
2.8 % | 1.46 % | -8.22 % |
|
Price to Book
|
2.12 | 3.59 | 0.82 |
|
P/E
|
218.77 | 228.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
211.9 Days | 185.52 Days | 11.27 Days |
|
Inventory Days
|
70.76 Days | 58.64 Days | 46.83 Days |
|
Days Receivable
|
147.75 Days | 164.3 Days | 10.61 Days |
|
Days Payable
|
44.01 Days | 29.07 Days | 83.41 Days |
|
5yr Average Interest Coverage Ratio
|
1.77 | 2.12 | -18.91 |
|
5yr Avg ROCE
|
8.99 % | 8.53 % | 1.03 % |
|
5yr Avg Operating Profit Margin
|
9.07 % | 7.35 % | 9.99 % |
|
5 yr average Debt to Equity
|
0.47 | 2.33 | 0.2 |
|
5yr CAGR Net Profit
|
12.89 % | 16.17 % | n/a |
|
5yr Average Return on Assets
|
1.89 % | 1.43 % | -5.59 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
63.65 % | 62.62 % | 53.65 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 20.66 % |
|
Change in Promoter Holding (3 Yrs)
|
-0.87 % | -12.38 % | 9.87 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Vilin Bio Med
|
Bandaram Pharma Pack
|
Lasa Supergenerics
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|